LFCR logo

LIFECORE BIOMEDICAL INC

LFCRNASDAQ
๐Ÿ† #3182 by market capEarnings Nov 3US Equity
$4.83โ–ฒ $0.18 (+3.65%)
๐ŸŒ… Pre-market$4.60โ–ผ 4.76%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ฒ 3.6%
7dโ–ฒ 8.9%
14dโ–ฒ 11.7%
30dโ–ฒ 4.2%
1yโ–ผ 36.6%
๐ŸฆMarket Cap
$181M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+27.6%
High Growth
๐Ÿ“ŠGross Margin
30.0%
Moderate
๐Ÿ’ตFCF Margin
6.3%
Moderate
โš–๏ธP/S Ratio
1.1x
Cheap
Otter Score
66
Fair

Trading Snapshot

Day Range
$4.78 โ€“ $4.85
52-Week Range
$3.63 โ€“ $8.98
Volume
$2.61B
Avg Volume
$3.22B
Shares Outstanding
37.5M
Next Earnings
Sep 1, 2026

Fundamentals Snapshot

Annual Revenue
$34M
Last Q Revenue
$34M
P/E Ratio
โ€”
P/S Ratio
1.1x
EPS (TTM)
$-1.18
Dividend Yield
โ€”

Why Investors Own LFCR

  • โœ“High-growth profile โ€” revenue up +48.4% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 53% gross margin and 25% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$34Mโ–ฒ +48.1% YoY
Gross Margin (TTM)
53.2%โ–ฒ +1.0% YoY
Operating Income (TTM)
$11Mโ–ฒ +48.1% YoY
Free Cash Flow (TTM)
$9Mโ–ฒ +48.1% YoY

About LIFECORE BIOMEDICAL INC

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Fair
66/100

Analyst Ratings

โ“˜
Consensus
Buy
11 analysts
Strong Buy4
Buy4
Hold3
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates